OTCQX
KHRNF

Khiron Life Sciences Corp

Drug Manufacturers-Specialty & Generic
Healthcare

Prices are adjusted according to historical splits.

Khiron Life Sciences Corp Stock Price

Vitals

Today's Low:
$0.0104
Today's High:
$0.0124
Open Price:
$0.0124
52W Low:
$0.009
52W High:
$0.126
Prev. Close:
$0.01
Volume:
173176

Company Statistics

Market Cap.:
$6.97 million
Book Value:
0.125
Revenue TTM:
$16.14 million
Operating Margin TTM:
-108.07%
Gross Profit TTM:
$6.37 million
Profit Margin:
-190%
Return on Assets TTM:
-20.79%
Return on Equity TTM:
-74.68%

Company Profile

Khiron Life Sciences Corp had its IPO on under the ticker symbol KHRNF.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Khiron Life Sciences Corp has a staff strength of 0 employees.

Stock update

Shares of Khiron Life Sciences Corp opened at $0.01 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.01 - $0.01, and closed at $0.01.

This is a +6% increase from the previous day's closing price.

A total volume of 173,176 shares were traded at the close of the day’s session.

In the last one week, shares of Khiron Life Sciences Corp have slipped by -24.29%.

Khiron Life Sciences Corp's Key Ratios

Khiron Life Sciences Corp has a market cap of $6.97 million, indicating a price to book ratio of 0.4495 and a price to sales ratio of 0.5404.

In the last 12-months Khiron Life Sciences Corp’s revenue was $16.14 million with a gross profit of $6.37 million and an EBITDA of $-16406023. The EBITDA ratio measures Khiron Life Sciences Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Khiron Life Sciences Corp’s operating margin was -108.07% while its return on assets stood at -20.79% with a return of equity of -74.68%.

In Q3, Khiron Life Sciences Corp’s quarterly earnings growth was a positive 0% while revenue growth was a negative 3.8%.

Khiron Life Sciences Corp’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-0.11 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Khiron Life Sciences Corp’s profitability.

Khiron Life Sciences Corp stock is trading at a EV to sales ratio of 0.5695 and a EV to EBITDA ratio of -0.3215. Its price to sales ratio in the trailing 12-months stood at 0.5404.

Khiron Life Sciences Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$38.45 million
Total Liabilities
$9.06 million
Operating Cash Flow
$-872000.00
Capital Expenditure
$749000
Dividend Payout Ratio
0%

Khiron Life Sciences Corp ended 2024 with $38.45 million in total assets and $0 in total liabilities. Its intangible assets were valued at $38.45 million while shareholder equity stood at $27.10 million.

Khiron Life Sciences Corp ended 2024 with $0 in deferred long-term liabilities, $9.06 million in other current liabilities, 151868000.00 in common stock, $-127971000.00 in retained earnings and $6.11 million in goodwill. Its cash balance stood at $1.94 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $1.34 million.

Khiron Life Sciences Corp’s total current assets stands at $18.33 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $4.54 million compared to accounts payable of $6.76 million and inventory worth $9.81 million.

In 2024, Khiron Life Sciences Corp's operating cash flow was $-872000.00 while its capital expenditure stood at $749000.

Comparatively, Khiron Life Sciences Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.01
52-Week High
$0.126
52-Week Low
$0.009
Analyst Target Price
$

Khiron Life Sciences Corp stock is currently trading at $0.01 per share. It touched a 52-week high of $0.126 and a 52-week low of $0.126. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.02 and 200-day moving average was $0.04 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 464.2% of the company’s stock are held by insiders while 21.6% are held by institutions.

Frequently Asked Questions About Khiron Life Sciences Corp

The stock symbol (also called stock or share ticker) of Khiron Life Sciences Corp is KHRNF

The IPO of Khiron Life Sciences Corp took place on

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price
Chg
Chg%
$0
-0.11
-99.55%
Alankit Limited (531082)
$11.13
-0.57
-4.87%
$373.4
-23.75
-5.98%
$11.81
0.75
+6.78%
$293.3
-3.15
-1.06%
$404.7
-29.75
-6.85%
$132.2
-11.35
-7.91%
$8.58
0
+14.57%
$0.02
0
0%
$18.8
-0.23
-1.21%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Address

500 Burrard Street, Vancouver, BC, Canada, V6C 2B5